Abstract
Optimal use of anthelmintics in children is of major public health importance because the parasites involved probably infect over 2 billion persons, and most are especially common and debilitating in children. Well targeted drug delivery, particularly via community chemotherapy, can substantially decrease aggregate morbidity and mortality and also improve growth rates, physical fitness and activity, cognitive and school performance, and social well-being.
The drugs discussed here include the benzimidazoles (albendazole, levamisole and mebendazole), pyrantel, praziquantel, oxamniquine, ivermectin, diethylcarbamazine and some traditional medicines. The parasitic infections discussed are hookworm, ascariasis, trichuriasis, strongyloidiasis, schistosomiasis and lymphatic filariasis; onchocerciasis and loiasis are also mentioned briefly. Dosage regimens and effectiveness, including combination treatment, are discussed. Mechanisms by which parasites may cause or aggravate malnutrition and retard development are shown, along with examples of nutritional and functional improvement at various ages due to antiparasitic treatment.
Improvement in appetite is likely to be the single most important mechanism through which a variety of physiological improvements occur. We recommend community treatment of girls and women of childbearing age in areas with widespread hookworm and anaemia, because effective treatment can reduce the incidence of low birthweight, mortality in infancy and pregnancy, and stunted growth and morbidity in children and adults. Treatment of moderate-to-severe anaemia improves appetite, growth and cognitive and school performance in children, and also improves work and social capacity and productivity in children and adults. Since treatment for helminth infections may also decrease both the probability of contracting HIV infection and the rate of viral replication in those infected with both types of organisms, large-scale treatment and control of helminths and treatment of individual cases when diagnosed are now truly urgent.
Similar content being viewed by others
References
Crompton DWT. How much human helminthiasis is there in the world? J Parasitol 1999; 85: 397–403
Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16: 187–91
Borkow G, Bentwich Z. Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis. Bull World Health Organ 2000; 78: 1368–9
Gopinath R, Ostrowski M, Justement ST, et al. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis 2000; 182: 1804–8
van den Biggelaar A, van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for para site-induced interleukin-10. Lancet 2000; 356(9243): 1723–7
Michael E, Bundy DA, Hall A, et al. This wormy world: fifty years on: the challenge of controlling common helminthiases of humans today [poster]. Parasitol Today 1997; 13(11): Insert
Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology 2000; 121 Suppl.: S23–38
World Bank. World development report: investing in health. Oxford: Oxford University Press, 1993
Chan MS. The global burden of intestinal nematode infections: fifty years on. Parasitol Today 1997; 13: 438–43
Bundy DA, Chan MS, Medley GF, et al. Intestinal nematode infections. In: Health priorities and burden of disease analysis: methods and applications from global, national and sub-national studies. Boston (MA): Harvard University Press for the WHO and World Bank. In press
Murray CJL, Lopez AD, editors. Global comparative assessments in the health sector, disease burden, expenditures and intervention packages. Geneva: World Health Organization, 1994
Montresor A, Gyorkos TW, Crompton DWT, et al. Monitoring helminth control programmes: guidelines for monitoring the impact of control programmes aimed at reducing morbidity caused by soil-transmitted helminths and schistosomes, with particular reference to school-age children. Geneva: World Health Organization, 1999. WHO/CDS/CPC/SIP/99.3.
O’Lorcain P, Holland CV. The public health importance of Ascaris lumbricoides. Parasitology 2000; 121 Suppl.: S51–72
ACC/SCN. Fourth report on the world nutrition situation. Geneva: ACC/SCN in collaboration with IFPRI, 2000 Jan
Stephenson LS, Latham MC, Ottesen EA. Global malnutrition. Parasitology 2000; 121 Suppl.: S5–22
Scrimshaw NS, Sangiovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997; 66 Suppl.: 464–77S
Montresor A, Crompton DWT, Hall A, et al. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. Geneva: World Health Organization, 1998. WHO/CTD/SIP/98.1
World Health Organization. Report of the WHO informal consultation on monitoring of drug efficacy in the control of schistosomiasis and intestinal nematodes. Geneva: World Health Organization, 1999. WHO/CDS/CPC SIP/99.1
Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382–6
Brown KR, Ricci FM, Ottesen EA. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 2000; 121 Suppl.: S133–46
Horton J, Witt C, Ottesen EA, et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000; 121 Suppl.: S147–60
Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000; 121 Suppl.: S113–32
Ottesen EA, Duke BOL, Karam M, et al. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75(6): 491–503
World Health Organization. Prevention and control of intestinal parasitic infections. Geneva: World Health Organization, 1987. Technical report series no. 749.
World Health Organization. Report of the WHO informal consultation on hookworm infection and anaemia in girls and women, Geneva: World Health Organization; 1994 Dec 5–7. WHO/CDS/IPI/95.1
Chodakewitz J. Ivermectin and lymphatic filariasis: a clinical update. Parasitol Today 1995; 11: 233–5
Moulia-Pelat JP, Glaziou P, Weil GJ, et al. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Trop Med Parasitol 1995; 46: 9–12
Ottesen EA, Ramachandran CP. Lymphatic filariasis infection and disease: control strategies. Parasitol Today 1995; 11: 129–31
Ismail MM, Jayakody RL, Weil GJ, et al. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1998; 92: 94–7
Beach MJ, Streit TG, Addiss DG, et al. Assessment of combined ivermectin and albendazole treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian school children. Am J Trop Med Hyg 1999; 60: 479–86
Ismail MM, Jayakody RL. Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka. Ann Trop Med Parasitol 1999; 93: 501–4
Savioli L, Renganathan E, Montresor A, et al. Control of schistosomiasis: a global picture. Parasitol Today 1997; 13(11): 444–8
Xiao SH, Booth M, Tanner M. The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 2000; 16(3): 122–6
Stephenson LS, Holland CV, Cooper ES. The public health significance of Trichuris trichiura. Parasitology 2000; 121 Suppl.: S73–96
Stephenson LS, Latham MC, Kurz KM. Treatment with a single dose of albendazole improves growth of Kenyan school children with hookworm, Trichuris trichiura, and Ascaris lumbricoides infections. Am J Trop Med Hyg 1989; 41: 78–87
Stephenson LS, Latham MC, Kurz KM, et al. Single metrifonate or praziquantel treatment in Kenyan children, II: effects on growth in relation to S. haematobium and hookworm egg counts. Am J Trop Med Hyg 1989; 41: 453–61
Simeon DT, Grantham-Mcgregor SM, Callendar JE, et al. Treatment of Trichuris trichiura infections improves growth, spelling scores and school attendance in some children. J Nutr 1995; 125: 1875–83
Stephenson LS, editor. Schistosomiasis and malnutrition. Cornell International Nutrition Monograph Series. Ithaca (NY): Cornell University, 1986
Stoltzfus RJ, Chwaya HM, Montresor A, et al. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J Nutr 2000; 130: 1724–33
Greenberg BL, Gilman RH, Shapiro H, et al. Single dose piperazine therapy for Ascaris lumbricoides: an unsuccessful method of promoting growth. Am J Clin Nutr 1981; 34: 2508–16
Latham MC, Stephenson LS, Kurz KM. Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections. Am J Trop Med Hyg 1990; 43: 170–9
Kvalsvig JD, Becker PJ. Selective exposure of active and sociable children to schistosomiasis. Ann Trop Med Parasitol 1988; 82: 471–4
Mahendra Raj S. Intestinal geohelminthiasis and growth in preadolescent primary school children in Northeastern Peninsular Malaysia. Southeast Asian J Trop Med Pub Health 1998; 29: 112–7
Parraga IM, Assis AM, Prado MS, et al. Gender differences in growth of school-aged children with schistosomiasis and geohelminth infection. Am J Trop Med Hyg 1996; 55: 150–6
Crompton DWT. The public health importance of hookworm disease. Parasitology 2000; 121 Suppl.: S39–50
Stephenson LS, Holland CV. The impact of helminth infections on human nutrition. London: Taylor & Francis, 1987
ACC/SCN. Second report on the world nutrition situation. Vol. 1. Global and regional results. Geneva: ACC/SCN, 1992
Stephenson LS, Latham MC, Adams EJ, et al. Physical fitness, growth and appetite of Kenyan school boys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J Nutr 1993; 123: 1036–46
Hadju V, Stephenson LS, Abadi K, et al. Improvements in appetite and growth in helminth-infected schoolboys three and seven weeks after a single dose of pyrantel pamoate. Parasitology 1996; 113: 497–504
Stephenson LS. The impact of schistosomiasis on human nutrition. Parasitology 1993; 107 Suppl.: S107–23
Stephenson LS, Latham MC, Adams EJ, et al. Weight gain of Kenyan school children infected with hookworm, Trichuris trichiura and Ascaris lumbricoides is improved following once- or twice-yearly treatment with albendazole. J Nutr 1993; 123: 656–65
Stephenson LS, Latham MC, Kurz KM, et al. Relationships of Schistosoma haematobium, hookworm and malarial infections and metrifonate treatment to growth of Kenyan school children. Am J Trop Med Hyg 1985; 34: 1109–18
Pollitt E. Malnutrition and infection in the classroom. Paris: UNESCO, 1990
Connolly KJ, Kvalsvig JD. Infection, nutrition and cognitive performance in children. Parasitology 1993; 107 Suppl.: S187–200
Nokes C, Bundy DA. Does helminth infection affect mental processing and educational achievement? Parasitol Today 1994; 10: 14–8
Watkins WE, Pollitt E. ‘Stupidity or worms’: do intestinal worms impair mental performance? Psychol Bull 1997; 121: 171–91
Guyatt H. Do intestinal nematodes affect productivity in adulthood? Parasitol Today 2000; 16: 153–8
Nokes C, Grantham-Mcgregor SM, Sawyer AW, et al. Moderate to heavy infections of Trichuris trichiura affect cognitive function in Jamaican school children. Parasitology 1992; 104: 539–47
Rose W. The Rockefeller Foundation International Health Board sixth annual report (1919 Jan 1–Dec 31). New York (NY): The Rockefeller Foundation, 1920
Mendez MA, Adair LS. Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J Nutr 1999; 129: 1555–62
Partnership For Child Development. Short stature and the age of enrolment in primary school: studies in two African countries. Soc Sci Med 1999; 48: 675–82
Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997; 66 Suppl.: 460–3S
Acknowledgements
The author thanks Dr E.A. Ottesen, Filariasis Elimination, Division of Communicable Diseases (CEE/FIL), World Health Organization, Geneva for reviewing the medical content of the manuscript and providing important suggestions; B. Seely and C. Hunt for excellent technical support; and the Division of Nutritional Sciences, Cornell University and its graduate students for institutional support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stephenson, L.S. Optimising the Benefits of Anthelmintic Treatment in Children. Paediatr Drugs 3, 495–508 (2001). https://doi.org/10.2165/00128072-200103070-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-200103070-00002